Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Situation and questions regarding the practice of blood cultures in paediatric patients: an opinion paper.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2026
Same author

Questions and issues of nonventilated hospital-acquired pneumonia: an opinion document.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma.

Current opinion in infectious diseases·2026
Same author

A rapid surveillance of pneumonia in hospitalized patients: an opportunity for intervention.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2026
Same author

Corrigendum to "In vitro study to assess modulation of <i>Candida</i> biofilm by <i>Escherichia coli</i> from vaginal strains" [Biofilm 5 (2023) 100116].

Biofilm·2025
Same author

Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?

Current opinion in infectious diseases·2025

Related Experiment Video

Updated: Jun 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Chlamydophila pneumoniae.

Almudena Burillo1, Emilio Bouza

  • 1Clinical Microbiology Department, Hospital Universitario de Móstoles, C/Río Júcar, s/n, 28935 Móstoles, Madrid, Spain.

Infectious Disease Clinics of North America
|February 23, 2010
PubMed
Summary
This summary is machine-generated.

Chlamydophila pneumoniae causes some pneumonia and bronchitis, often with mild symptoms. Diagnosis and treatment present challenges due to delayed detection and uncertain therapeutic benefits.

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Related Experiment Videos

Last Updated: Jun 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Area of Science:

  • Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Chlamydophila pneumoniae is a significant cause of community-acquired pneumonia (CAP) and bronchitis.
  • Infections are often mild and asymptomatic, with a long incubation period and persistent symptoms.
  • Current diagnostic methods are delayed and lack FDA-cleared standardization.

Purpose of the Study:

  • To review the challenges in diagnosing and treating Chlamydophila pneumoniae infections.
  • To discuss the current therapeutic strategies and their limitations.
  • To highlight the need for improved diagnostic and treatment approaches.

Main Methods:

  • Literature review of Chlamydophila pneumoniae infections.
  • Analysis of diagnostic methods and their timeliness.
  • Evaluation of antibiotic efficacy and treatment guidelines.

Main Results:

  • Chlamydophila pneumoniae accounts for approximately 10% of CAP and 5% of bronchitis cases.
  • Diagnosis is often delayed, hindering timely and effective treatment.
  • Evidence for clinical benefit from first-line antibiotics like erythromycin, tetracycline, and doxycycline is debated.
  • Prospective studies are limited by ethical and logistical issues.

Conclusions:

  • Despite diagnostic and therapeutic challenges, antimicrobial treatment for C. pneumoniae respiratory infections is recommended by North American guidelines.
  • Further research is needed to develop accurate diagnostic tools and confirm treatment efficacy.
  • Addressing diagnostic delays and treatment uncertainties is crucial for managing C. pneumoniae infections.